Results 131 to 140 of about 1,125 (150)
Glycolysis Inhibition Restores Immune Sensitivity in GSNOR–Deficient Colorectal Cancer
S-nitrosoglutathione reductase (GSNOR) is increasingly recognized as a tumor suppressor, and we have recently reported that its deficiency drives an aggressive and immune-evasive phenotype in colorectal cancer (CRC). However, the mechanisms linking GSNOR loss to immune escape remain incompletely understood.
Antonio Rodriguez-Ariza +2 more
exaly +3 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
NEDD4–Mediated GSNOR Degradation Aggravates Cardiac Hypertrophy and Dysfunction
Circulation ResearchBACKGROUND: The decrease in S-nitrosoglutathione reductase (GSNOR) leads to an elevation of S-nitrosylation, thereby exacerbating the progression of cardiomyopathy in response to hemodynamic stress. However, the mechanisms under GSNOR decrease remain unclear.
Xin Tang +21 more
openaire +2 more sources
GSNOR Impaired Cognitive Function in Aging Through De-Nitrosation of CamKIIalpha
Free Radical Biology and Medicine, 2016As a result of the acceleration of population aging, an increasing number of people suffer from age related cognitive impairment. However, the mechanisms that underlie this process are unclear. Here we found that S-nitrosoglutathione reductase (GSNOR), the key enzyme metabolizing the intracellular nitric oxide (NO) and S-nitrosation, significantly ...
Zhang Yuying, Chen Chang
openaire +1 more source
Activation of GSNOR transcription by NF-κB negatively regulates NGF-induced PC12 differentiation
Free Radical Research, 2014S-nitrosoglutathione reductase (GSNOR) is the key enzyme controlling the intracellular levels of S-nitrosoglutathione and S-nitrosothiols. GSNOR has been implicated in many biological processes, such as the cardiovascular and respiratory systems. However, the role of GSNOR, the sole brain alcohol dehydrogenase, in the nervous systems is still largely a
K, Wu +5 more
openaire +2 more sources
Design, Synthesis, and Anti-ischemic Stroke Activity Evaluation of Novel GSNOR Inhibitors
Journal of Medicinal ChemistryS-nitrosoglutathione reductase (GSNOR), a key regulator of protein S-nitrosation, is a promising therapeutic target for cerebral ischemia. We report the design, synthesis, and evaluation of indole-based GSNOR inhibitors with potent anti-ischemic activity.
Zhuangzhuang Liang +14 more
openaire +2 more sources
Targeting GSNOR deficiency as a new therapeutic approach in rhabdomyosarcoma
Free Radical Biology and Medicine, 2023Giovanni Larotondo +5 more
openaire +1 more source

